Kyle Niessen possesses a robust background in biomedical research and development, with experience spanning multiple prestigious organizations. Niessen served as a Post-Doctoral Fellow at Genentech from February 2008 to August 2012 and gained additional experience as a Research Technician at Simon Fraser University in 2001. Following this, a significant role as a Scientist at Elan Pharmaceuticals was held from August 2012 to April 2013. Subsequently, a tenure at Pfizer Centers for Therapeutic Innovation as a Senior Scientist occurred from September 2013 to March 2016. Niessen continued at Pfizer from March 2016 to January 2020, taking on leadership positions as Principal Scientist and Research Project Lead, as well as Field Medical Director for Breast Cancer and Malignant Hematology. Educational qualifications include a PhD in Experimental Medicine from The University of British Columbia, obtained between 2002 and 2007, and a BSc in Molecular Biology and Biochemistry from Simon Fraser University, earned from 1997 to 2001.
This person is not in the org chart
This person is not in any teams
This person is not in any offices